Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
17.02
-0.16 (-0.93%)
At close: Dec 5, 2025, 4:00 PM EST
17.07
+0.05 (0.29%)
After-hours: Dec 5, 2025, 7:50 PM EST
Healthpeak Properties Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Healthpeak Properties stock ranges from a low of $18 to a high of $25. The average analyst price target of $20.3 forecasts a 19.27% increase in the stock price over the next year.
Price Target: $20.30 (+19.27%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 6 | 7 | 6 | 5 | 4 |
| Hold | 3 | 4 | 4 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 12 | 12 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +11.63% | Nov 25, 2025 |
| Baird | Baird | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +17.51% | Nov 12, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $20 | Hold | Initiates | $20 | +17.51% | Oct 1, 2025 |
| Raymond James | Raymond James | Hold → Buy Upgrades $20 | Hold → Buy | Upgrades | $20 | +17.51% | Sep 15, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $20 → $18 | Hold | Maintains | $20 → $18 | +5.76% | Aug 27, 2025 |
Financial Forecast
Revenue This Year
2.80B
from 2.70B
Increased by 3.50%
Revenue Next Year
2.86B
from 2.80B
Increased by 2.25%
EPS This Year
0.23
from 0.36
Decreased by -35.62%
EPS Next Year
0.27
from 0.23
Increased by 15.69%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.0B | 3.1B | ||||
| Avg | 2.8B | 2.9B | ||||
| Low | 2.7B | 2.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.0% | 11.3% | ||||
| Avg | 3.5% | 2.3% | ||||
| Low | -0.8% | -2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 0.25 | 0.35 | ||||
| Avg | 0.23 | 0.27 | ||||
| Low | 0.20 | 0.16 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -29.7% | 50.1% | ||||
| Avg | -35.6% | 15.7% | ||||
| Low | -45.3% | -32.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.